highperformr logo

Actavis (now Allergan)'s Overview

Total employees1376
HeadquartersDublin
Founded1984

Actavis plc was a global pharmaceutical company focused on developing, manufacturing, and distributing generic, brand, and biosimilar products. Through a series of strategic acquisitions, including Warner Chilcott (2013) and Forest Laboratories (2014), Actavis grew significantly. In a transformative move in 2015, Actavis acquired Allergan, Inc. and subsequently adopted the Allergan name, becoming Allergan plc. Later, in 2016, Teva Pharmaceutical Industries acquired Allergan's global generics business (the former Actavis Generics). The remaining Allergan plc was then acquired by AbbVie in 2020. This page reflects information primarily about Actavis plc prior to its renaming and the divestiture of its generics arm.

Where is Actavis (now Allergan)'s Headquarters?

Actavis (now Allergan) officeActavis (now Allergan) officeActavis (now Allergan) officeActavis (now Allergan) office
*Images sourced via web search. Rights belong to original owners

HQ Function

Corporate headquarters for Actavis plc, overseeing global strategy, finance, legal operations, and governance.

Notable Features:

Modern office facilities designed to support global executive functions and corporate governance for a multinational pharmaceutical company.

Work Culture:

A dynamic, fast-paced, and growth-oriented environment, heavily influenced by frequent M&A activities and the integration of diverse company cultures. Strong emphasis on efficiency in generics and innovation in specialty pharmaceuticals.

HQ Significance:

The Irish domicile was strategically important for tax efficiency, global operational management, and access to European markets.

Values Reflected in HQ: Global ambition, strategic financial planning, operational agility, and a commitment to growth through acquisition and development.

Location:

Historically, Actavis plc operated on a global scale, with a robust presence across North America, Europe, Asia-Pacific, and other regions. Its worldwide functions encompassed research and development centers, numerous manufacturing facilities, commercial sales and marketing offices, and extensive distribution networks. Actavis marketed its products in more than 60 countries, supporting both its extensive generic pharmaceuticals portfolio and its growing specialty branded business.

Street Address:

Clonshaugh Industrial Estate (historical administrative/operational base) / Corporate Domicile: 1 Grand Canal Square, Docklands (as it transitioned to Allergan plc)

City:

Dublin

State/Province:

Dublin

Country:

Ireland

Actavis (now Allergan)'s Global Presence

Parsippany, New Jersey, USA

Address: Morris Corporate Center III, 400 Interpace Parkway, Parsippany, NJ 07054, USA (Historical U.S. Headquarters)

Key center for the North American market, housing significant leadership, drug development activities, and corporate support functions for many years.

Hafnarfjörður, Iceland

Address: Reykjavíkurvegur 78, 220 Hafnarfjörður, Iceland (Historical)

Key manufacturing and development hub, particularly for European markets, and a link to the company's heritage.

Buying Intent Signals for Actavis (now Allergan)

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Actavis (now Allergan)

As of April 2025, Actavis (now Allergan)' leadership includes:

Paul M. Bisaro - Executive Chairman (formerly President and CEO)
Brenton L. (Brent) Saunders - CEO and President
Sigurdur (Siggi) Olafsson - President, Global Generic Medicines
Robert A. Stewart - Chief Operating Officer (formerly President, Global Operations)
Maria Teresa (Tessa) Hilado - Chief Financial Officer

Investors of Actavis (now Allergan)

Actavis (now Allergan) has been backed by several prominent investors over the years, including:

As a publicly traded company on the New York Stock Exchange (ticker: ACT, prior to delisting/acquisition), Actavis plc's ownership was distributed among a diverse group of institutional and individual shareholders. Prominent institutional investors typically included major asset management firms such as BlackRock, The Vanguard Group, State Street Corporation, and Fidelity Management & Research (FMR), which are common holders of large-cap pharmaceutical stocks. Specific holdings fluctuated with market activity.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

The 2014-2015 period for Actavis was characterized by significant M&A activity, including the acquisition of Forest Laboratories and Allergan, Inc., leading to pivotal leadership appointments and transitions. These changes were instrumental in shaping the company's strategic direction and growth.

Departures

Paul M. Bisaro, Paul M. Bisaro transitioned from his role as President and CEO to become Executive Chairman of Actavis plc.

New Appointments:

Brenton L. (Brent) Saunders, Brent Saunders was appointed CEO and President of Actavis plc, joining from Forest Laboratories.
Paul M. Bisaro, Paul M. Bisaro assumed the new role of Executive Chairman of Actavis plc.

Technology (Tech Stack) used by Actavis (now Allergan)

Discover the tools Actavis (now Allergan) uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Actavis (now Allergan) Email Formats and Examples

While Actavis as a standalone entity has been acquired and restructured (generics by Teva, remainder into Allergan then AbbVie), its historical email formats likely followed common corporate patterns. These domains (@actavis.com) are no longer actively used for the original company.

Common formats historically included: [first_initial][last]@actavis.com (e.g., jdoe@actavis.com) and [first].[last]@actavis.com (e.g., jane.doe@actavis.com).

Format

j.doe@actavis.com

Example

70%

Success rate

News and media

PR Newswire / Company Press Release (Archived)March 17, 2015

Actavis Completes Allergan Acquisition, Adopts Allergan Name

Actavis plc announced it successfully completed its acquisition of Allergan, Inc. The combined company was renamed Allergan plc, creating a global pharmaceutical leader with expanded capabilities in brand development and generics....more

Company Press Release / FiercePharma (Archived reporting)July 1, 2014

Actavis Completes Acquisition of Forest Laboratories and Announces New Leadership

Actavis plc completed its $25 billion acquisition of Forest Laboratories. Brent Saunders, then CEO of Forest, was appointed CEO and President of the combined company, Actavis plc. Paul Bisaro, Actavis's then-CEO, became Executive Chairman....more

Teva Pharmaceutical Industries Press ReleaseAugust 2, 2016

Teva Completes Acquisition of Actavis Generics from Allergan

Teva Pharmaceutical Industries Ltd. announced the completion of its acquisition of Allergan plc's global generics business (Actavis Generics). This acquisition significantly strengthened Teva's position as a global leader in generic pharmaceuticals....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Actavis (now Allergan), are just a search away.